Resolution of Experimental Malaria-Associated Acute Respiratory Distress Syndrome Is Alox12 Independent and Shows Residual Inflammation

The study on malaria-associated acute respiratory distress syndrome (MA-ARDS) in mice finds that resolution is independent of the Alox12 pathway, despite its role in inflammation regulation. Targeting the 12-lipoxygenase pathway with inhibitors or supplements did not improve survival or resolution outcomes. Persistent inflammation, altered chemokine expression, and incomplete metabolic recovery were observed during resolution. The study suggests that multi-targeted therapies, beyond antimalarial drugs, are needed to effectively address the complex processes of pathogen elimination, inflammation suppression, and tissue repair in MA-ARDS. The research involved 4 mice per group for gene expression analysis.